Determining Value: A Biotech Industry Discussion on Value Assessments and Alternative Proposals

11:00 AM - 12:00 PM (EDT), Tuesday, June 6, 2023 ・ Session Room 210A
Determining Value: Perspectives on Value Assessments, Value Calculations, and a Discussion of Ways to Enhance Current Methods and Narratives and Wholistically Assess a Medicine’s Value

Much has been discussed surrounding the “value” an innovative medicine brings to a patient but little has been said about how that value is determined and why these assessment methodologies are deployed. Industry stakeholders will unpack the concept of value and discuss methods for patients, investors, providers, and manufacturers to have a voice in how the ecosystem thinks about a medicine’s value – both to a patient and to the broader ecosystem of stakeholders who are impacted by innovation and medical interventions. Hear from a broad array of industry stakeholders: investors; manufacturers; non-profits; and patient advocates as we discuss how to transition the narrative surrounding value to one that fairly and comprehensively assesses the true innovation delivered by novel biotech therapies.
Chief Policy Officer
Founder and Managing Partner
RA Capital
Professor of Pharmaceutical Economics and Public Policy Quintiles Chair in Pharmaceutical and Regulatory Innovation; Director of Research, Schaeffer Center
University of Southern California
Vice President, Head of Global Health Economics and Value
Principal and Founder; Senior Fellow, Center for the Evaluation of Value and Risk in Health
Valusphere; Tufts Medical Center